Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Task Force To Develop Approaches To Nanotechnology In Drugs, Foods

This article was originally published in The Tan Sheet

Executive Summary

FDA's Nanotechnology Task Force will identify policy gaps related to the use of nanotechnology particles to evaluate possible adverse health effects from products that contain the materials, the agency said
Advertisement

Related Content

Nanotech grant
Nanotech grant
Nanotech grant
Nanotech Report’s Recommendations Unsettling To Supplement Industry
Commercialization Phase Brings New Challenges To Nanotech Industry
Multilayer Emulsions Deliver Goods For Nano-Engineered Food – Researchers
2008 Budget Should Cover Research On Nanotech Risk – Congressmen
Nanotech Boom Presents Challenges For Both Industry, Regulators
Nanotech Experts Question Whether Regulatory “Gaps” Affect Consumers
CTFA Comments Challenge Public Interest Coalition On Sunscreen Ingredients

Topics

Advertisement
UsernamePublicRestriction

Register

PS099662

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel